Articoli con mandati relativi all'accesso pubblico - Christine MarosiUlteriori informazioni
Non disponibili pubblicamente: 4
Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with the risk of thromboembolism and mortality in patients with cancer
E Grilz, F Posch, O Königsbrügge, I Schwarzinger, IM Lang, C Marosi, ...
Thrombosis and haemostasis 118 (11), 1875-1884, 2018
Mandati: Austrian Science Fund
Risk assessment scores for cancer-associated venous thromboembolic disease
D Angelini, AA Khorana
Seminars in thrombosis and hemostasis 43 (05), 469-478, 2017
Mandati: US National Institutes of Health
Anti-glioma efficacy and mechanism of action of tripolinolate A from Tripolium pannonicum
W Chai, L Chen, XY Lian, Z Zhang
Planta Medica 84 (11), 786-794, 2018
Mandati: National Natural Science Foundation of China
Multicentric malignant glioma with striking morphologic heterogeneity and early and extensive metastatic spread to the bone
P Nadine, T Roetzer, J Furtner, B Kiesel, M Herac, M Susani, D Capper, ...
Clinical Neuropathology 38 (6), 261, 2019
Mandati: Austrian Science Fund
Disponibili pubblicamente: 30
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ...
The lancet oncology 18 (6), e315-e329, 2017
Mandati: German Research Foundation
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
AS Berghoff, B Kiesel, G Widhalm, O Rajky, G Ricken, A Wöhrer, ...
Neuro-oncology 17 (8), 1064-1075, 2015
Mandati: Austrian Science Fund
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ...
The Lancet Oncology 17 (11), 1521-1532, 2016
Mandati: US National Institutes of Health, National Health and Medical Research …
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
Mandati: US National Institutes of Health
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome …
P Bady, D Sciuscio, AC Diserens, J Bloch, MJ Van Den Bent, C Marosi, ...
Acta neuropathologica 124, 547-560, 2012
Mandati: Swiss National Science Foundation
Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J THALER, C Ay, N Mackman, RM Bertina, A Kaider, C Marosi, NS Key, ...
Journal of Thrombosis and Haemostasis 10 (7), 1363-1370, 2012
Mandati: US National Institutes of Health
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
J Klughammer, B Kiesel, T Roetzer, N Fortelny, A Nemc, KH Nenning, ...
Nature medicine 24 (10), 1611-1624, 2018
Mandati: Austrian Science Fund, European Commission
Correlation of immune phenotype with IDH mutation in diffuse glioma
AS Berghoff, B Kiesel, G Widhalm, D Wilhelm, O Rajky, S Kurscheid, ...
Neuro-oncology 19 (11), 1460-1468, 2017
Mandati: Swiss National Science Foundation
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
A Pace, L Dirven, JAF Koekkoek, H Golla, J Fleming, R Rudà, C Marosi, ...
The Lancet Oncology 18 (6), e330-e340, 2017
Mandati: UK Medical Research Council
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
J Riedl, M Preusser, PMS Nazari, F Posch, S Panzer, C Marosi, P Birner, ...
Blood, The Journal of the American Society of Hematology 129 (13), 1831-1839, 2017
Mandati: Austrian Science Fund
Clinical fMRI: evidence for a 7 T benefit over 3 T
R Beisteiner, S Robinson, M Wurnig, M Hilbert, K Merksa, J Rath, ...
Neuroimage 57 (3), 1015-1021, 2011
Mandati: Austrian Science Fund
Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation …
W Wick, T Gorlia, P Bady, M Platten, MJ Van Den Bent, MJB Taphoorn, ...
Clinical cancer research 22 (19), 4797-4806, 2016
Mandati: Swiss National Science Foundation
FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities
S Allerstorfer, G Sonvilla, H Fischer, S Spiegl-Kreinecker, C Gauglhofer, ...
Oncogene 27 (30), 4180-4190, 2008
Mandati: Austrian Science Fund
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
S Kurscheid, P Bady, D Sciuscio, I Samarzija, T Shay, I Vassallo, ...
Genome biology 16, 1-15, 2015
Mandati: Swiss National Science Foundation, Swiss Cancer League
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer
E Grilz, LM Mauracher, F Posch, O Königsbrügge, S Zöchbauer‐Müller, ...
British journal of haematology 186 (2), 311-320, 2019
Mandati: Austrian Science Fund
A novel tool to analyze MRI recurrence patterns in glioblastoma
W Wick, R Stupp, AC Beule, J Bromberg, A Wick, U Ernemann, M Platten, ...
Neuro-oncology 10 (6), 1019-1024, 2008
Mandati: German Research Foundation
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software